Targeting PD1–PDL1 immune checkpoint in plasmacytoid dendritic cell interactions with T cells, natural killer cells and multiple myeloma cells

@article{Ray2015TargetingPI,
  title={Targeting PD1–PDL1 immune checkpoint in plasmacytoid dendritic cell interactions with T cells, natural killer cells and multiple myeloma cells},
  author={Arghya Ray and Deepika Sharma Das and Yan Song and Paul Richardson and Nikhil C. Munshi and Dharminder Chauhan and Kenneth C. Anderson},
  journal={Leukemia},
  year={2015},
  volume={29},
  pages={1441-1444}
}
they bear mutations in p53. Genes Dev 2014; 28: 58–70. This work is licensed under a Creative Commons AttributionNonCommercial-NoDerivs 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicatedotherwise in the credit line; if thematerial is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 11 times. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 51 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 19 references

Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy.

Clinical cancer research : an official journal of the American Association for Cancer Research • 2014

The 39th David A. Karnofsky Lecture: bench-to-bedside translation of targeted therapies in multiple myeloma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2012

inhibit T cell proliferation

JM Taube, A Klein, +3 authors JH Kim
Sci Signal 2012; • 2012

Similar Papers

Loading similar papers…